Skip to content

Sionna Therapeutics, Inc.

SION Nasdaq SEC CIK 2036042

Follow Sionna Therapeutics Weekly email: filings, results, news

News

4 stories filed under Sionna Therapeutics, grouped into ongoing threads

Cystic fibrosis

Thread · 2 stories

Sionna Therapeutics, Inc. (SION) Discusses Clinical Trial Results and Discontinuation of 719 Program in Cystic Fibrosis - Slideshow

Markets 45 d ago

STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial

Markets 45 d ago

More coverage

Sionna's SION-719 Failure Changes Everything (Rating Downgrade)

Markets 43 d ago

Why is Sionna Therapeutics stock collapsing today?

Markets 45 d ago 2 sources

Profile

Headquarters: WALTHAM, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 4 stories clustered from the RSS aggregator